Telemachus Therapeutics, Inc.

Amendment
CIK: 0002152986·Pharmaceuticals·DELAWARE·Filed: Oct 28, 2026
Total Offering

$1,500,000

Amount Sold

$375,000

Investors

3

First Sale

Aug 20, 2026

Offering Details

Type
Option to Acquire, Security to be Acquired, Other: Simple Agreement for Future Equity (SAFE)
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2026
Non-Accredited Investors
No

Related Persons

NameRole
Michael Bozik
Related Person
Gregory Hebrank
Related Person

Company

Telemachus Therapeutics, Inc.

401 WOODHAVEN DRIVE

WEXFORD, PA, 15090

412-527-6630

SEC Filing

0002152986-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Telemachus Therapeutics, Inc. Form D Filing — $1,500,000 | FilingFlow